Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 34

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 34
---
21 |

| Adjustments to Summary Compensation Table amounts to CAP amounts                                                 |     | 2024 
 PEO  |            |   |     | Average 
 Non-PEO 
 NEOs    |            |   |     | 2023 
 PEO  |            |   |     | Average 
 Non-PEO 
 NEOs    |            |   |     | 2022 
 PEO  |            |   |     | Average 
 Non-PEO 
 NEOs    |            |   |
|:-----------------------------------------------------------------------------------------------------------------|:----|:-----|-----------:|:--|:----|:--------|-----------:|:--|:----|:-----|-----------:|:--|:----|:--------|-----------:|:--|:----|:-----|-----------:|:--|:----|:--------|-----------:|:--|
| Summary Compensation Table                                                                                       |     | $    |  3,476,037 |   |     | $       |  1,760,002 |   |     | $    |  3,639,651 |   |     | $       |  1,965,876 |   |     | $    |  2,159,033 |   |     | $       |  1,848,558 |   |
| Grant Date FV of option awards granted in fiscal year                                                            |     |      | (2,093,000 | ) |     |         | (1,046,500 | ) |     |      | (2,354,100 | ) |     |         | (1,177,050 | ) |     |      | (1,088,000 | ) |     |         | (1,297,600 | ) |
| FV at year-end of outstanding and unvested option awards granted in fiscal year                                  |     |      |  1,104,143 |   |     |         |    552,072 |   |     |      |  1,013,134 |   |     |         |    506,567 |   |     |      |  1,843,723 |   |     |         |  2,229,667 |   |
| Vesting date FV of awards granted in fiscal year and vested in fiscal year                                       |     |      |    385,700 |   |     |         |